ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for discussion 같은 생각을 가진 투자자들과 토론할 수 있는 활발한 포럼에서 상호 작용하려면 등록하세요.

VVOS Vivos Therapeutics Inc

2.63
0.00 (0.00%)
04 5월(5) 2024 - 마감
15분 지연
기업명 주식 심볼 시장 주식 타입
Vivos Therapeutics Inc VVOS 나스닥 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
0.00 0.00% 2.63 09:00:00
개장가 저가 고가 종가 전일 종가
2.70 2.56 2.715 2.63 2.63
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
09/04/202420:30GLOBEVivos Therapeutics’ Flagship CARE Oral Medical Devices..
29/03/202405:05GLOBEVivos Therapeutics Reports Fourth Quarter and Full Year 2023..
28/03/202420:30GLOBEVivos Therapeutics Schedules Release of Fourth Quarter and..
15/02/202422:55EDGAR2Form 8-K - Current report
15/02/202422:00GLOBEVivos Therapeutics Announces Exercise of Warrants for..
15/02/202407:42EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
06/02/202421:30GLOBEVivos Therapeutics Highlights Significant Favorable Market..
08/01/202421:30GLOBEVivos Therapeutics Sees Positive Preliminary Metrics..
11/12/202321:30GLOBEVivos Therapeutics Presents Groundbreaking Event:..
04/12/202314:15EDGAR2Form EFFECT - Notice of Effectiveness
02/12/202306:12EDGAR2Form 424B1 - Prospectus [Rule 424(b)(1)]
01/12/202306:05EDGAR2Form 8-K - Current report
01/12/202306:03EDGAR2Form S-1/A - General form for registration of securities..
29/11/202321:30GLOBEVivos Therapeutics Receives First Ever FDA 510(k) Clearance..
23/11/202306:46EDGAR2Form S-1 - General form for registration of securities under..
15/11/202306:05GLOBEVivos Therapeutics Reports Third Quarter 2023 Financial..
10/11/202306:30GLOBEVivos Therapeutics Schedules Release of Third Quarter 2023..
04/11/202306:00EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
03/11/202306:10EDGAR2Form 8-K - Current report
03/11/202306:00GLOBEVivos Therapeutics Closes $4 Million Private Placement
31/10/202321:00GLOBEVivos Therapeutics Announces Pricing of $4 Million Private..
28/10/202305:15EDGAR2Form 8-K - Current report
26/10/202320:30GLOBEVivos Therapeutics Announces Reverse Stock Split
24/10/202320:30GLOBEVivos Therapeutics Signs Nationwide Distribution Agreement..
11/10/202320:30GLOBEVivos Therapeutics to Begin Clinical Trial at Stanford..
05/10/202320:30GLOBEVivos Therapeutics Announces Strategic Collaboration in the..
05/10/202304:55APSBiotech Soars On New Agreements
04/10/202320:30GLOBEVivos Therapeutics Executes Strategic Agreements with Ormco..
02/10/202320:30GLOBENew York Times Best-Selling Author James Nestor to Headline..
25/09/202322:00EDGAR2Form 8-K - Current report
22/09/202306:10EDGAR2Form 8-K - Current report
15/09/202305:38EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
07/09/202306:26EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
28/08/202322:00EDGAR2Form DEF 14A - Other definitive proxy statements
21/08/202322:00EDGAR2Form 8-K - Current report
17/08/202305:45EDGAR2Form PRE 14A - Other preliminary proxy statements
17/08/202305:30EDGAR2Form 8-K - Current report
17/08/202305:16EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
17/08/202305:05GLOBEVivos Therapeutics Reports Second Quarter 2023 Financial..
16/08/202320:30GLOBEVivos Therapeutics Reschedules Second Quarter 2023 Financial..
15/08/202306:06GLOBEVivos Therapeutics to Reschedule Second Quarter 2023..
11/08/202309:31GLOBEVivos Therapeutics Schedules Release of Second Quarter 2023..
09/06/202305:05GLOBEVivos Therapeutics Reports First Quarter 2023 Financial..
07/06/202305:30GLOBEVivos Therapeutics Schedules Release of First Quarter..
09/05/202320:30GLOBEVivos Therapeutics Announces Additional Strategic..

최근 히스토리

Delayed Upgrade Clock